Researchers have designed highly effective catalysts to make hydrogen directly from seawater, which is key to reducing the strain on freshwater resources and avoiding the energy-intensive and carbon-emitting desalination process.
Most European consumers will remember the phasing out of incandescent light bulbs. At the time, replacement technologies were available but unpopular in the market place, with higher initial costs and perceived poorer performance. But this regulatory intervention precipitated a seismic shift in the development efforts of the lighting industry.
The small and mid-cap sector of the chemical industry has undergone broad structural change over the last decade. We have witnessed significant consolidation, numerous mergers, spinoffs, active portfolio restructuring, and selected privatisations. All these actions have been designed to improve performance and reposition companies to succeed in a changing market environment.
Read the latest Advanced Materials highlights in C&I Magazine Issue 1 2023 written by Arno Kraft, Heriot-Watt University, Edinburgh, UK.
Read the latest applied chemistry highlights for April 2023 by Nigel P Freestone | University of Northampton, UK.
The rocks of a remote desert valley in Oman are already absorbing up to 100,000t of CO2 every year – around one gram of CO2/m3 of stone. But with a little bit of help, they could absorb even more. Jasmin Fox-Skelly reports.
A cure for baldness is some way off but understanding why hair follicles ‘switch off’ – and overcoming this – could form the basis of potential treatments. Lou Reade reports
The textbook picture of graphene as a flat surface is wrong. Instead, graphene contains nanoripples, which explains why it can act as a strong catalyst, according to Andre Geim at the University of Manchester, UK.
Insulin may not be working in diabetes as expected, according to researchers. Now, a study with an advanced single molecule microscope has revealed some surprises.
A UK centre is to be set up to accelerate the development of animal vaccines to take on emerging and urgent infectious diseases. The new Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM) will be based at the Pirbright Institute in Surrey, UK, and funded by a non-profit organisation and government.